Inlet View, Inc. (SYM: SYM) holder files to sell 4,000 shares

Rhea-AI Filing Summary

A holder of Common A Shares of the issuer has filed a notice under Rule 144 to sell 4,000 shares through Goldman Sachs & Co. LLC on the NASD, with an aggregate market value of 216,520. The filing states that 123,250,254 shares of this class are outstanding and targets an approximate sale date of 02/02/2026.

The 4,000 shares were originally acquired from the issuer in a public offering on 05/05/2022. Over the past three months, the same account reported three separate sales of 4,000 Common A Shares each, with gross proceeds of 283,983.2, 307,005.6, and 274,506.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common A Shares	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	4000	216520	123250254	02/02/2026	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common A Shares	05/05/2022	Acquired from issuer in public offering	The Issuer			4000	05/05/2022	None

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Inlet View, Inc. 200 Research Drive Wilmington MA 01887	Common A Shares	12/03/2025	4000	283983.2
Inlet View, Inc. 200 Research Drive Wilmington MA 01887	Common A Shares	11/04/2025	4000	307005.6
Inlet View, Inc. 200 Research Drive Wilmington MA 01887	Common A Shares	01/05/2026	4000	274506

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for SYM disclose about planned share sales?

The Form 144 for SYM discloses a planned sale of 4,000 Common A Shares. The shares are to be sold through Goldman Sachs & Co. LLC on the NASD, with an aggregate market value reported as 216,520 and an approximate sale date of 02/02/2026.

How many SYM Common A Shares are outstanding according to this notice?

The notice states that 123,250,254 Common A Shares are outstanding. This figure provides context for the planned Rule 144 sale of 4,000 shares, indicating the relative size of the proposed transaction compared with the total shares of this class currently outstanding.

When and how were the SYM shares in this Form 144 originally acquired?

The 4,000 SYM Common A Shares were acquired on 05/05/2022 from the issuer in a public offering. The filing indicates the nature of the transaction as an acquisition from the issuer, with the date of payment also listed as 05/05/2022.

What past three-month SYM share sales are reported in this Form 144?

The filing lists three sales of 4,000 Common A Shares each in the past three months. These occurred on 11/04/2025, 12/03/2025, and 01/05/2026, with gross proceeds of 307,005.6, 283,983.2, and 274,506 respectively for the reported transactions.

Which broker will handle the planned SYM Rule 144 share sale?

The planned Rule 144 sale of SYM Common A Shares will be handled by Goldman Sachs & Co. LLC. The broker’s address is given as 200 West Street, New York, NY 10282, and the sale is expected to take place on the NASD marketplace.

What representation does the selling holder make in the SYM Form 144?

The selling holder represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is made by signing the notice, as required under Rule 144.